Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoic acid, also known as ethyl (2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoate, is a chemical compound with the molecular formula C11H20O4. It is an ester derivative of (2R)-2-acetoxymethyl-4-methylpentanoic acid and is commonly used in the pharmaceutical and chemical industries. This versatile compound has a wide range of potential uses in different industries.

181289-10-1

Post Buying Request

181289-10-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

181289-10-1 Usage

Uses

Used in Pharmaceutical Industry:
(2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoic acid is used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into various drug structures, contributing to the development of new medications.
Used in Chemical Industry:
(2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoic acid is used as a building block in organic synthesis, allowing for the creation of a variety of complex organic compounds for different applications.
Used in Drug Development:
(2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoic acid is utilized in the development of various drugs, playing a crucial role in the formulation and synthesis of novel therapeutic agents.
Used in Production of Fine Chemicals:
(2R)-2-[(ethoxycarbonyl)methyl]-4-methylpentanoic acid is employed in the production of fine chemicals, which are high-purity chemicals used in various applications such as research, pharmaceuticals, and specialty industries.

Check Digit Verification of cas no

The CAS Registry Mumber 181289-10-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,2,8 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 181289-10:
(8*1)+(7*8)+(6*1)+(5*2)+(4*8)+(3*9)+(2*1)+(1*0)=141
141 % 10 = 1
So 181289-10-1 is a valid CAS Registry Number.

181289-10-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-2-(2-ethoxy-2-oxoethyl)-4-methylpentanoic acid

1.2 Other means of identification

Product number -
Other names (2R)-2-[(ETHOXYCARBONYL)METHYL]-4-METHYLPENTANOIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:181289-10-1 SDS

181289-10-1Downstream Products

181289-10-1Relevant articles and documents

Enzymatic preparation of homochiral 2-isobutyl succinic acid derivatives

Wirz, Beat,Soukup, Milan

, p. 187 - 189 (1997)

An efficient enzymatic procedure for the enantio- and regioselective monohydrolysis of diethyl 2-isobutyl succinate 3 using subtilisin Carlsberg has been developed. The product (R)-2-isobutyl succinic acid 4-ethyl ester 4, a collagenase inhibitor building block, was obtained in high enantiomeric excess (> 99%) and yield (> 45%). Similarly, (R)-2-isobutyl succinic acid 4-nitrile 2 was produced in 98% ee from its ethyl ester 1.

IMPROVED SYNTHESIS OF OPTICALLY PURE (S) - 3-CYANO-5-METHYL-HEXANOIC ACID ALKYL ESTER, AN INTERMEDIATE OF (S)- PREGABALIN

-

Page/Page column 53-54, (2011/12/02)

The present invention is directed towards synthesis of (S) - 3-cyano-5-methyl-hexanoic acid ethyl ester. A cost effective, eco-friendly process for preparation of enantiomerically pure (S)-3-cyano-5-methyl-hexanoic acid alkyl ester, intermediate of γ-amino acids, particularly (S)-pregabalin.

INHIBITORS OF ANTHRAX LETHAL FACTOR

-

, (2008/06/13)

Methods, compounds and compositions for preventing and treating anthrax infections by inhibiting Anthrax Lethal Factor (LF) activity.

Hydroxamic acid based collagenase inhibitors

-

, (2008/06/13)

Thid disclosure relates to a novel class of hydroxamic acid based collagenase inhibitor derivatives. The disclosure further relates to pharmaceutical compositions containing such compounds and to the use of such compounds and compositions in the treatment

Hydroxamic acid based collagenase inhibitors

-

, (2008/06/13)

This disclosure relates to a novel class of hydroxamic acid based collagenase inhibitor derivatives. The disclosure further relates to pharmaceutical compositions containing such compounds and to the use of such compounds and compositions in the treatment

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 181289-10-1